GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AddLife AB (OSTO:ALIF B) » Definitions » EV-to-FCF

AddLife AB (OSTO:ALIF B) EV-to-FCF : 24.90 (As of May. 23, 2024)


View and export this data going back to 2016. Start your Free Trial

What is AddLife AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AddLife AB's Enterprise Value is kr19,052 Mil. AddLife AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was kr765 Mil. Therefore, AddLife AB's EV-to-FCF for today is 24.90.

The historical rank and industry rank for AddLife AB's EV-to-FCF or its related term are showing as below:

OSTO:ALIF B' s EV-to-FCF Range Over the Past 10 Years
Min: 17.07   Med: 26.86   Max: 50.53
Current: 25.22

During the past 11 years, the highest EV-to-FCF of AddLife AB was 50.53. The lowest was 17.07. And the median was 26.86.

OSTO:ALIF B's EV-to-FCF is ranked better than
55.8% of 362 companies
in the Medical Devices & Instruments industry
Industry Median: 28.055 vs OSTO:ALIF B: 25.22

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), AddLife AB's stock price is kr113.20. AddLife AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.650. Therefore, AddLife AB's PE Ratio for today is 174.15.


AddLife AB EV-to-FCF Historical Data

The historical data trend for AddLife AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AddLife AB EV-to-FCF Chart

AddLife AB Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.31 19.58 57.99 29.42 39.46

AddLife AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.39 36.68 19.69 39.46 24.72

Competitive Comparison of AddLife AB's EV-to-FCF

For the Medical Instruments & Supplies subindustry, AddLife AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AddLife AB's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where AddLife AB's EV-to-FCF falls into.



AddLife AB EV-to-FCF Calculation

AddLife AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=19052.012/765
=24.90

AddLife AB's current Enterprise Value is kr19,052 Mil.
AddLife AB's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr765 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AddLife AB  (OSTO:ALIF B) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

AddLife AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=113.20/0.650
=174.15

AddLife AB's share price for today is kr113.20.
AddLife AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.650.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


AddLife AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of AddLife AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


AddLife AB (OSTO:ALIF B) Business Description

Traded in Other Exchanges
Address
Brunkebergstorg 5, Box 3145, Stockholm, SWE, 103 62
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.

AddLife AB (OSTO:ALIF B) Headlines

No Headlines